KEVIN LIEBMANN: Open Payments
NPI 1154939064 · PRINCETON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$832 in 35 payments from 15 companies in 2025. Trend: 2023 $483 · 2024 $406 · 2025 $832
Food & beverage: $652Education: $179
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 9 | $141 |
| Regeneron Healthcare Solutions, Inc. | 3 | $134 |
| Stryker Corporation | 2 | $119 |
| ABBVIE INC. | 5 | $93 |
| Janssen Biotech, Inc. | 1 | $80 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 3 | $48 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $40 |
| Galderma Laboratories, L.P. | 2 | $37 |
| Lilly USA, LLC | 2 | $35 |
| Journey Medical Corporation | 1 | $22 |
Products named: OPZELURA, DUPIXENT, TREMFYA, SKYRIZI, ORTHOLOC 3DI, T2 ALPHA, Cabtreo, NEMLUVIO.
Industry payments across NJ — which companies pay providers there.
